GMP Nutraceuticals
X-Ray Contrast MediaHepacept®
synergistic composition of plant extracts
The herbs contained in Hepacept® are traditionally known for their anti-inflammatory properties and are utilized as preventative agents as well as nutritional supplements for the medical treatment of chronic inflammation of various organs such as the liver, urinary bladder, intestines and the joints.
The composition of Hepacept® is based on synergies of its active principles discovered in our laboratories. Developed by Biophysica, Inc. of La Jolla, California, and Interpharma Praha, Hepacept® contains the following concentrated, purified and analytically standardized herbal extracts (in mg per 1 g of the composition):
Extract from the resin of Olibanum tree (165 mg) Boswellia serrata
- contains 60 - 70 % by weight boswellic acids and other active triterpenes
more info about the product: “Bioswellix”
Resveratrol extract (200 mg)
- contains min. 50 % by weight trans-resveratrol
Extract of the root of Baical skullcap (165 mg) Scutellaria baicalensis
- contains min. 80 % by weight baicalin monohydrate
Extract of the root of turmeric (334 mg) Curcuma longa
- contains min. 90 % by weight curcuminoids
Extract of the fruit
of Milk thistle (133 mg) Silybum
marianum
- contains min. 60 % silymarin (UV), min. 30% by weight silybinin (HPLC)
Extract from dried
fruits of black pepper (3 mg) Piper
nigrum
- contains min. 90 % by weight piperine
These individual herbs are used in traditional Ayurvedic and Asian folk medicines. Baical skullcap, for example, is part of the traditional Japanese treatment for chronic inflammation, including that of the liver and its sequel, liver cirrhosis. Boswellia resin is used in India for allergic and other conditions suggesting its immuno-modulating properties.
Resveratrol is also used for a variety of inflammatory and neoplastic diseases in traditional chinese medicine.
Silymarin, derived from Milk thistle, is a well-known and widely used herbal substance listed in several Pharmacopoeias as an adjuvant treatment for chronic liver inflammation. Studies in animals and human subjects have shown Silymarin to assist the body, especially the liver, in providing protection against toxic substances, such as the side effects of chemotherapeutics, and in working synergistically with the drugs to enhance therapeutic effects. For example, Silymarin have been found to reduce toxic effects of cisplatin upon the kidneys in animals without compromising the drug's anti-tumor activity. Similar tests involving adriamycin have found similar results. For the corresponding scientific referrences, please click here:
A small amount of piperine, extracted from black pepper, has been added as it was shown to increase oral absorption.
Hepacept® components are effective antioxidants and free-radical scavengers. They have also been reported to be inhibitors of unregulated cell growth, which occurs under conditions such as inflammation and neoplastic afflictions. Curcumin, derived from Turmeric, is one of the most extensively studied.
This product is prepared, analyzed and certified under Good Manufacturing Practice rules in a plant inspected by the National Regulatory Authorities.
This product was developed by Interpharma Praha in collaboration with Biophysica, Inc. of San Diego, California.